LendÃnez-Jurado, A.; López-Siguero, J.P.; Gómez-Perea, A.; Ariza-Jiménez, A.B.; Becerra-Paz, I.; Tapia-Ceballos, L.; Cruces-Ponce, C.; Jiménez-Hinojosa, J.M.; Morcillo, S.; Leiva-Gea, I.
Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy? J. Clin. Med. 2023, 12, 6951.
https://doi.org/10.3390/jcm12216951
AMA Style
LendÃnez-Jurado A, López-Siguero JP, Gómez-Perea A, Ariza-Jiménez AB, Becerra-Paz I, Tapia-Ceballos L, Cruces-Ponce C, Jiménez-Hinojosa JM, Morcillo S, Leiva-Gea I.
Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy? Journal of Clinical Medicine. 2023; 12(21):6951.
https://doi.org/10.3390/jcm12216951
Chicago/Turabian Style
LendÃnez-Jurado, Alfonso, Juan Pedro López-Siguero, Ana Gómez-Perea, Ana B. Ariza-Jiménez, IcÃa Becerra-Paz, Leopoldo Tapia-Ceballos, Carmen Cruces-Ponce, José Manuel Jiménez-Hinojosa, Sonsoles Morcillo, and Isabel Leiva-Gea.
2023. "Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?" Journal of Clinical Medicine 12, no. 21: 6951.
https://doi.org/10.3390/jcm12216951
APA Style
LendÃnez-Jurado, A., López-Siguero, J. P., Gómez-Perea, A., Ariza-Jiménez, A. B., Becerra-Paz, I., Tapia-Ceballos, L., Cruces-Ponce, C., Jiménez-Hinojosa, J. M., Morcillo, S., & Leiva-Gea, I.
(2023). Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy? Journal of Clinical Medicine, 12(21), 6951.
https://doi.org/10.3390/jcm12216951